The breast and ovarian cancer susceptibility gene BRCA1 encodes a nuclear phosphoprotein, which functions as a tumor suppressor gene. Many studies suggested that multiple functions of BRCA1 may contribute to its tumor suppressor activity, including roles in cell cycle checkpoints, apoptosis and transcription. It is postulated that phosphorylation of BRCA1 is an important means by which its cellular functions are regulated. In this study, we employed phospho-Ser-specific antibody recognizing Ser-1524 to study BRCA1 phosphorylation under conditions of DNA damage and the effects of phosphorylation on BRCA1 functions. The results showed that 10 Gy X-ray treatment significantly induced phosphorylation of Ser-1524 but not total BRCA1 protein leve...
Women carrying germline mutations of the BRCA1 gene show an increased risk of breast and ovarian can...
The defect in homologous recombination (HR) found in BRCA1-associated cancers can be therapeutically...
Abstract Background The breast cancer susceptibility ...
BRCA1 is mutated in the germline of 20-40% of women with hereditary susceptibility to breast and ova...
BRCA1 has been proposed to be tightly linked to the resistance of tumorcells to ionizing radiation. ...
In the present study, we investigated the mechanisms of apoptosis resistance and the roles of the ph...
Studies of factors contributed to the development of hereditary breast and ovary cancers lead to the...
BRCAI, the familial breast cancer susceptibility gene product, is a 220-kDa phosphorylated protein. ...
Background: Germ-line mutations of the breast cancer susceptibility gene-1 (BRCA1) increase the susc...
BACKGROUND: Germ-line mutations of the breast cancer susceptibility gene-1 (BRCA1) increase the susc...
BRCA1 is a phosphoprotein involved in many biological processes, including transcription, ubiquitina...
The hereditary breast and ovarian tumor suppressor BRCA1 can activate p53-dependent gene expression....
The participation of BRCA1 (breast cancer 1) in DNA repair is well established, especially in mammar...
Germ-line mutations of the breast cancer susceptibility gene-1 (BRCA1) increase the susceptibility t...
Germline mutations to BRCA1 account for approximately 30% of familial breast cancer, with carriers h...
Women carrying germline mutations of the BRCA1 gene show an increased risk of breast and ovarian can...
The defect in homologous recombination (HR) found in BRCA1-associated cancers can be therapeutically...
Abstract Background The breast cancer susceptibility ...
BRCA1 is mutated in the germline of 20-40% of women with hereditary susceptibility to breast and ova...
BRCA1 has been proposed to be tightly linked to the resistance of tumorcells to ionizing radiation. ...
In the present study, we investigated the mechanisms of apoptosis resistance and the roles of the ph...
Studies of factors contributed to the development of hereditary breast and ovary cancers lead to the...
BRCAI, the familial breast cancer susceptibility gene product, is a 220-kDa phosphorylated protein. ...
Background: Germ-line mutations of the breast cancer susceptibility gene-1 (BRCA1) increase the susc...
BACKGROUND: Germ-line mutations of the breast cancer susceptibility gene-1 (BRCA1) increase the susc...
BRCA1 is a phosphoprotein involved in many biological processes, including transcription, ubiquitina...
The hereditary breast and ovarian tumor suppressor BRCA1 can activate p53-dependent gene expression....
The participation of BRCA1 (breast cancer 1) in DNA repair is well established, especially in mammar...
Germ-line mutations of the breast cancer susceptibility gene-1 (BRCA1) increase the susceptibility t...
Germline mutations to BRCA1 account for approximately 30% of familial breast cancer, with carriers h...
Women carrying germline mutations of the BRCA1 gene show an increased risk of breast and ovarian can...
The defect in homologous recombination (HR) found in BRCA1-associated cancers can be therapeutically...
Abstract Background The breast cancer susceptibility ...